Stride variability measures derived from wrist- and hip-worn
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Abstract:	 Many	 epidemiological	 and	 clinical	 studies	 use	 accelerometry	 to	objectively	measure	physical	activity	using	the	activity	counts,	vector	magnitude,	or	number	of	steps.	These	measures	use	 just	a	 fraction	of	 the	 information	 in	 the	raw	accelerometry	data	as	they	are	typically	summarized	at	the	minute	level.	To	address	this	problem	we	define	and	estimate	two	gait	measures	of	temporal	stride-to-stride	variability	based	on	raw	accelerometry	data:	Amplitude	Deviation	(AD)	and	Phase	Deviation	(PD).	We	explore	the	sensitivity	of	our	approach	to	on-body	placement	of	the	accelerometer	by	comparing	hip,	 left	and	right	wrist	placements.	We	 illustrate	the	 approach	 by	 estimating	 AD	 and	 PD	 in	 46	 elderly	 participants	 in	 the	Developmental	 Epidemiologic	 Cohort	 Study	 (DECOS)	 who	 worn	 accelerometers	during	 a	 400	meter	 walk	 test.	We	 also	 show	 that	 AD	 and	 PD	 have	 a	 statistically	significant	association	with	the	gait	speed	and	sit-to-stand	test	performance.			
1 Introduction		Accelerometers	 are	 now	 ubiquitous	 in	 health	 studies,	 where	 they	 are	 used	 to	provide	 objective	 and	 reproducible	 proxy	 measurements	 of	 physical	 activity.	Examples	 of	 such	 studies	 include	 both	 large	 epidemiological	 cohorts,	 such	 as	 the	National	Health	and	Nutrition	Examination	Survey	(NHANES) [1]	and	the	Baltimore	Longitudinal	Study	of	Aging	(BLSA)	[2],	and	clinical	studies	of	chronic	disease,	such	as	Alzheimer’s	Disease [3],	Multiple	Sclerosis	[4]	and	Heart	Disease	[5].	The	primary	activity	measurements	 in	 these	 studies	 are	 usually	 limited	 to	 crude	 summaries	 of	the	24-hour	activity	cycle	such	as	the	total	daily	activity	count,	vector	magnitude,	or	number	 of	 steps.	 	 When	 walking	 is	 of	 primary	 scientific	 interest,	 steps-based	summaries	provide	useful	information	about	“how	much”	and	“when”	the	person	is	walking,	 but	 do	 not	 provide	 any	 information	 about	 “how”	 the	 person	 is	walking	 or	
“whether”	 their	 walking	 changes	 during	 the	 course	 of	 the	 day.	 This	 type	 of	information	 can	 be	 crucial	 in	 clinical	 and	 observational	 studies	 as	 it	 provides	information	about	the	intrinsic	walking	parameters	and	their	associated	variability.	Understanding	the	association	between	these	parameters	and	levels	of	 fatigue	and	fatigability	 in	 healthy	 and	 frail	 populations	 is	 a	 major	 step	 towards	 identifying	parameters	that	are	intuitive,	can	easily	be	extracted	from	accelerometry	data,	and	are	 relevant	 to	 health	 studies.	 Quantifying	 gait	 parameters	 and	 ambulatory	monitoring	of	changes	 in	 these	parameters	has	become	 increasingly	 important	 for	epidemiological,	clinical	and	rehabilitation	studies.				Several	approaches	extracting	time-dependent	gait	parameters	were	developed	and	successfully	 applied	 to	 data	 collected	 from	 body-worn	 accelerometers	 [6] [7] [8].	The	proposed	approaches	demonstrated	significant	discriminative	power	in	studies	of	clinical	pathology [9] [10],	 fatigability [11] [12],	and	aging	  [13] [14] [15].	 	Stride-to-stride	 variability	 is	 an	 important	 gait	 parameter	 that	 quantifies	 participants’	ability	to	maintain	walking	consistency	and	is	strongly	associated	with	motor	ability 
[16] [17] [9].	 Stride-to-stride	 variability	 has	 been	 linked	 to	 Mild	 Cognitive	Impairment	 [18],	 dementia	 [19],	 and	 stroke	 [20].	 One	 of	 the	 limitations	 of	 current	approaches	 is	 that	 they	 are	 based	 on	 data	 obtained	 from	 accelerometers	 placed	around	 the	middle	of	 the	body	 (hip,	 lower	back)	 [21] [22].	However,	 research	has	recently	 shifted	 more	 towards	 wrist-worn	 accelerometers	 such	 as	 the	 Actigraph	Link,	GENEActiv	Watch,	Fitbit	Flex	and	Jawbone	Up.	This	shift	is	likely	due	to	their	ease	of	use,	 increased	compliance	of	 study	participants,	and	 improvements	 in	size	and	battery	life.		 [1].		This	shift	raises	new	challenges	to	estimating	gait	parameters,	as	hands	are	involved	in	a	much	wider	spectrum	of	activities,	which	results	in	higher	complexity	and	increased	within-	and	between-subject	variability [23].			We	 propose	 a	 method	 to	 extract	 two	 measures	 of	 stride-to-stride	 variability:	Amplitude	Deviation	(AD)	and	Phase	Deviation	(PD).	These	measures	are	based	on	the	amplitude	of	acceleration	and	duration	of	consecutive	strides,	respectively.	We	compare	the	performance	of	AD	and	PD	calculated	based	on	raw	accelerometry	data	obtained	 from	three	body	 locations:	 the	hip,	 the	 left	wrist,	and	the	right	wrist.	We	evaluate	 the	 sensitivity	 of	 AD	 and	 PD	 as	 a	 function	 of	 on-body	 placement	 in	 46	participants	of	the	Developmental	Epidemiologic	Cohort	Study	[24].	To	benchmark	AD	and	PD	against	standard	accelerometry	summaries	and	physical	 function	tests,	we	 evaluate	 their	 association	with	 four	measures:	 cadence	 (C),	 vector	magnitude	counts	(VMC),	time	on	Five-Times-Sit-To-Stand	(Chr5s)	test	[25]	and	usual	gait	speed	measured	on	a	6	meter	distance	test	(Pace6m)	[26].	
2 Methods	
2.1.1 Participants		
Data	 were	 collected	 as	 a	 part	 of	 the	 Developmental	 Epidemiologic	 Cohort	 Study	(DECOS)	[27],	a	study	of	older	adults	in	good	health.	Forty	six	participants	(25	males,	21	females;	age:	78±4	y.o.;	BMI:	26.75±3)	were	selected	for	the	analysis.		
2.1.2 Measurement	protocol		
Fast paced four hundred meter walk is a standardized test measuring physical function 
often employed by epidemiological studies [28]. The test consisted of 20 consecutive 
laps, 20 meters each. For each participant we chose data collected during the second lap 
of the 400 meters trial as it is expected that during this lap gait parameters are more likely 
to represent normal gait characteristics for each participant [29]. The reasons are that 
during the first lap individuals may try to outperform, experience larger variability in the 
first part of the experiment, while effects of fatigue are less likely to occur only after 20 
meters. During the task participants wore three ActiGraph GT3X+ devices (each with 
three orthogonal axes, sampling frequency: 80 observations/second) located on the hip, 
the left and right wrists. Data were collected in parallel from all three sensors and 
synchronized at the sub-second level between devices.  
2.2 Data	analysis		The	three-axial	acceleration	signal	was	first	reduced	to	the	vector	magnitude		 𝑟! =  𝑥!! + 𝑦!! + 𝑧!!,		which	is	less	sensitive	to	device	rotation	and	small	changes	in	position.	Here	x,	y,	z	are	 the	 acceleration	 signals	 measured	 along	 the	 three	 orthogonal	 axes	 and	 i	represents	time.	For	presentation	clarity	we	have	dropped	indices	corresponding	to	participant	and	sensor	locations.		We	used	fast	Fourier	transformation	of	the	vector	magnitude	data	from	the	second	lap	 of	 the	 400-meter	walk	 trial.	 For	 each	walk-trial	 and	 sensor	 location	 the	mean	cadence	C	was	estimated	by	identifying	the	spectral	peaks	corresponding	to	stride-to-stride	 frequency.	 Cadence	 is	 expressed	 in	 steps-per-second	 and	 is	 defined	 as	𝐶 =  𝑓 ⁄ 2,	where	 f	is	 the	 frequency	 location	of	 the	spectral	peak	corresponding	 to	stride-to-stride	frequency	(express	in	Hz).	To	express	cadence	in	steps	per	minute,	C	could	be	multiplied	by	60.	An	example	of	Fourier	spectrum	with	estimated	location	of	the	peak	of	interest	is	presented	in	the	top	panel	of	Figure	1.			To	 estimate	 the	 duration	 of	 consecutive	 strides,	 we	 first	 extracted	 the	 walking-specific	 signal	 using	 a	 band-pass	 filter	 ranging	 from	 0.75C	 to	 1.25C	 (where	 C	denotes	 cadence).	 	 The	 resulting	 signal	 can	 be	 interpreted	 as	 a	 periodic	 wave	 of	slowly	 varying	 instantaneous	 frequency	 that	 corresponds	 to	 durations	 of	consecutive	steps.	Duration	of	each	stride	 length	was	estimated	by	 localizing	even	zero-crossing	points	(see	fig.2	–	middle	panel).	
2.3 Strides	synchronization		After	the	data	transformation	steps	described	in	Section	2.2,	stride-specific	patterns	were	 time-synchronized.	 To	 do	 this,	 data	was	 first	 interpolated	 using	 splines	 and	then	 linearly	aligned	to	0	 to	1,	where	 location	0	marks	 the	beginning	of	 the	stride	cycle	while	1	marks	 its	end	(see	 fig.1	–	bottom	panel).	This	 transformation	allows	the	estimation	of	the	average	stride	profile	for	each	participant	and	sensor	location.	The	average	value	of	the	amplitude	of	the	acceleration	signal	within	the	stride-cycle	is	expressed	as:			 𝐴! = 1𝑀 𝑟!"!!!! ,		where	φ 	is	an	index	of	a	stride	phase	ranging	from	0	to	1	and	 j	denotes	the	stride	index.	 Examples	 of	 average	 stride	 acceleration	 profiles	 for	 all	 three	 locations	 are	displayed	in	figure	2.		
2.3.1 Stride	variability	measures		We	focus	on	two	measures	of	stride	variability	that	reflect	differences	in	amplitude	and	 phase.	 We	 define	 the	 stride-to-stride	 amplitude	 deviation	 (AD)	 as	 the	 mean	standard	deviation	of	synchronized	activity	count	profiles:			
𝐴𝐷 =  1𝑁 1𝑀 𝑟!" − 𝐴! !!!!!!!!! ,	where	 N	 is	 the	 number	 of	 samples	 for	 each	 synchronized	 profile,	 M	 is	 the	 total	number	of	consecutive	profiles,	and	Ai	denotes	the	average	stride	profile	at	sample	time	 i.	 We	 also	 define	 the	 stride-to-stride	 phase	 deviation	 (PD)	 as	 the	 standard	deviation	of	estimated	durations	of	strides:	
𝑃𝐷 =  1𝑀 𝑆! − 1𝑓 !!!!! ,	where	𝑆! 	denotes	 the	 duration	 of	 j-th	 stride	 expressed	 in	 seconds	 and	1/𝑓	is	 the	average	stride	length	estimated	in	Section	2.2.		
2.3.2 Additional	measures		Several	additional	parameters	were	estimated.	In	particular,	we	estimated	the	mean	cadence,	C,	 for	each	participant	and	device	location.	Cadence	was	calculated	as	the	inverse	of	the	average	stride	length	multiplied	by	a	factor	of	two	and	expressed	in	steps-per-minute.	 We	 have	 also	 computed	 the	 average	 vector	 magnitude	 count	
(VMC)	for	each	sensor	location.	VMC	is	defined	as	the	mean	absolute	deviation	of	the	acceleration	signal:		 𝑉𝑀𝐶 = 1𝑇 𝑟! −  1𝑇 𝑟!!!!! ,!!!! 		where	T	denotes	the	total	number	of	samples	for	each	gait	acceleration	signal.	
2.4 Dependent	variables	We	 compare	 the	 estimated	 measures,	 AD,	 PD,	 C	 and	 VMC,	 with	 performance	measures	obtained	from	standardized	tests	of	physical	function	administered	in	the	DECOS	study.	We	focused	on	the	five-times-sit-to-stand	(Chr5s)	test	(mean	=	0.4,	SD	=	0.1) [25]	and	the	usual	gait	speed	measured	by	a	6-meter	walk	(Pace6m)	test	(mean	=	1.1,	SD	=	0.2) [26].		
2.5 Statistical	analysis		The	 association	 between	 each	 stride	 characteristic	 and	 dependent	 variable	 was	evaluated	 using	 linear	 regression	 models.	 Each	 model	 was	 adjusted	 for	 age.	 The	estimated	 parameters	 and	 p-values	 for	 the	 null	 hypothesis	 of	 no	 association	 are	presented	 in	 table	 2.	 We	 have	 also	 calculated	 the	 correlation	 between	measurements	using	the	Spearman’s	rank	correlation	ρ.	Figure	3	displays	XY-plots	of	the	proposed	measures	and	the	estimated	correlation	coefficients.			
3 Results		We	compared	the	sensitivity	to	body	location	of	the	four	accelerometry-derived	gait	parameters	 then	 studied	 their	 association	 with	 standard	 measures	 of	 physical	function.		
3.1 Hip	vs.	Wrist	Placement		Figure	 3	 provides	 the	 pair-wise	 scatterplots	 (the	 upper	 triangle)	 and	 the	corresponding	Spearman’s	rank	correlations	(the	lower	triangle)	for	each	of	the	four	gait	 parameters.	 Stride-to-stride	 AD	 exhibits	 a	 relatively	 high	 left	 vs.	 right	 wrist	correlation	 (ρ =	0.67),	 and	a	 lower	 left-wrist	 versus	hip	 (ρ =	0.52)	and	 right-wrist	versus	 hip	 correlations	 (ρ =	 0.36).	 Stride-to-stride	 PD	 indicates	 higher	 left	 versus	right	 wrist	 correlation	 (ρ =	 0.67),	 and	 lower	 left-wrist	 versus	 hip	 (ρ =	 0.36)	 and	right-wrist	versus	hip	correlations	(ρ =	0.41).		The	estimated	PD	values	using	wrist	accelerometry	tend	to	be	larger	than	PD	values	obtained	using	hip	accelerometry.			VMC	exhibited	high	correlation	between	the	two	wrists		(ρ =	0.78)	and	between	the	hip	 and	 either	wrist	 (ρ =	0.79	 and	0.73,	 respectively).	 	 The	VMC	values	 estimated	
from	the	hip-worn	sensor	were	slightly	higher	than	those	obtained	from	wrist-worn	sensors.		Cadence	indicated	much	higher	correlation	across	all	three	locations	(ρ 	=	0.98,	0.99,	0.99)	without	significant	bias.				
3.2 Association	with	physical	function	tests			Table	2	provides	the	regression	coefficients	and	the	p-values	of	the	tests	for	the	null	hypothesis	 of	 no-association	 between	 the	 newly	 proposed	 measures	 of	 gait	 and	standard	 measures	 of	 physical	 function.	 Models	 are	 adjusted	 for	 age	 and	 were	applied	 separately	 for	 each	 sensor	 placement:	 hip	 (top	 panel),	 left	 wrist	 (middle	panel),	and	right	wrist	(bottom	panel).	AD	was	significantly	associated	with	Chr5s	for	all	 three	 locations	 (p	 <	 0.01)	 and	was	 significantly	 associated	with	Pace6m	 for	 the	hip-located	 sensor	 (p	=	0.014).	No	 significant	 relationship	was	 identified	between	PD	 and	 any	 of	 the	 dependent	 variables.	 Walking-related	 VMC	 was	 strongly	associated	with	 both	 Chr5s	 and	 Pace6m	 for	 all	 three	 locations	 (p	 <	 0.05).	 Cadence	estimated	from	data	collected	at	the	hip	was	significantly	associated	with	both	Chr5s	(p	 =	 0.043)	 and	 Pace6m	(p	 =	 0.037).	 Cadence	 estimated	 from	data	 collected	 at	 the	right	wrist	was	not	 statistically	 associated	with	Pace6m	 (p	=	 0.055)	 and	Chr5s	(p	 =	0.097).	 We	 have	 found	 statistically	 significant	 associations	 between	 the	 cadence	estimated	from	data	collected	at	the	left	wrist	and	Pace6m	(p	=	0.032)	but	not	with	Chr5s	(p	=	0.058).		
4 Discussion		We	 have	 proposed	 and	 examined	 two	 measures	 of	 stride-to-stride	 variability,	Amplitude	Deviation	and	Phase	Deviation,	estimated	 from	raw	accelerometry	data	collected	 during	 walking.	 AD	 was	 significantly	 associated	 with	 the	 standardized	performance	 tests,	 Chr5s	 and	 Pace6m	 across	 all	 three	 locations.	 	 PD	 was	 not	associated	with	these	tests.	As	our	population	represents	healthy	aging	participants	with	 no	 clinical	 diagnosis,	 PD	 has	 the	 potential	 for	 use	 in	 specific	 clinical	populations.			When	we	compared	AD	and	PD	across	the	three	on-body	locations,	gait	parameters	were	more	correlated	for	data	collected	from	the	 left	and	the	right	wrists	and	less	correlated	 for	 data	 collected	 from	 the	 wrist	 versus	 hip.	 The	 cadence	 (C)	 and	 the	vector	magnitude	count	(VMC)	are	consistently	associated	with	Chr5s	and	Pace6m.			A	limitation	of	all	wrist-based	accelerometry-derived	gait	parameters	is	that	sensors	record	arm	movement,	which	are	proxies	of	walking	strides	 [30].	Moreover,	 in	 the	free-living	 environment	 one	 would	 expect	 long	 periods	 of	 walking	 without	 arm	swinging	(e.g.	because	hands	are	in	the	pocket	or	handling	a	phone).	However,	our	results	 indicate	 the	 accelerometry-derived	 parameters	 can	 be	 useful	 in	 studies	 of	normative	 aging	 and	 may	 offer	 opportunities	 for	 monitoring	 temporal	 gait	variability	 in	 impaired	 populations.	 We	 conclude	 that	 raw	 accelerometry	 data	
contains	more	detailed	information	about	gait	characteristic	than	the	currently	used	actigraphy	summaries.	





















Hip	 VMC		 AD	 Cadence	 PD	Chr5s	 0.73(5.85e-06)		 1.54(0.000926)	 0.16(0.04348)	 -1.20(0.450201)	Pace6m	 -5.15(0.000369)	 -10.20(0.0143)	 -1.35(0.0366)	 20.00(0.1336)	
	
Left	wrist	 VMC	 AD	 Cadence	 PD	Chr5s	 0.31(0.002746)	 0.77(0.005161)	 0.13(0.09671)	 0.43(0.345273)	Pace6m	 -2.01(0.0272)	 -2.47(0.325)	 -1.24(0.0552)	 1.12(0.7768)	
	
Right	wrist	 VMC	 AD	 Cadence	 PD	Chr5s	 0.25(0.015096)	 0.85(0.001073)	 0.15(0.05840)	 0.65(0.15522)	Pace6m	 -1.95(0.0299)	 -2.66(0.268)	 -1.37(0.0323)	 0.57(0.8695)	Table	2.	Slope	coefficients	and	p-values	(in	brackets)	for	linear	regression	fit	using	proposed	values.	Shaded	fields	marks	values	above	significance	levels.			
		Fig.3.	Pair	plots	displaying	proposed	measures	against	each	other	with	red	identity	lines.	Panels	below	diagonals	return	Spearman’s	rank	correlation	coefficients.			
